Franklin Resources’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$649K Buy
49,856
+79
+0.2% +$1.03K ﹤0.01% 2193
2025
Q1
$527K Sell
49,777
-50,900
-51% -$539K ﹤0.01% 2232
2024
Q4
$1.71M Sell
100,677
-3,259
-3% -$55.3K ﹤0.01% 1777
2024
Q3
$2.17M Buy
103,936
+36,714
+55% +$768K ﹤0.01% 1709
2024
Q2
$1.64M Sell
67,222
-3,424
-5% -$83.4K ﹤0.01% 1759
2024
Q1
$2.39M Buy
70,646
+54,848
+347% +$1.85M ﹤0.01% 1654
2023
Q4
$498K Sell
15,798
-8
-0.1% -$252 ﹤0.01% 1937
2023
Q3
$404K Sell
15,806
-3,257
-17% -$83.2K ﹤0.01% 2018
2023
Q2
$547K Buy
+19,063
New +$547K ﹤0.01% 1920
2018
Q2
Sell
-56,711
Closed -$312K 1467
2018
Q1
$312K Sell
56,711
-582,931
-91% -$3.21M ﹤0.01% 1411
2017
Q4
$5.09M Sell
639,642
-1
-0% -$8 ﹤0.01% 1064
2017
Q3
$4.52M Hold
639,643
﹤0.01% 1071
2017
Q2
$5.02M Hold
639,643
﹤0.01% 1081
2017
Q1
$5.1M Hold
639,643
﹤0.01% 1102
2016
Q4
$9.4M Buy
639,643
+72,724
+13% +$1.07M ﹤0.01% 969
2016
Q3
$9.8M Buy
566,919
+45,072
+9% +$779K 0.01% 980
2016
Q2
$16.4M Hold
521,847
0.01% 857
2016
Q1
$13.8M Buy
521,847
+114,907
+28% +$3.05M 0.01% 895
2015
Q4
$17.9M Buy
406,940
+155,426
+62% +$6.83M 0.01% 869
2015
Q3
$10.6M Buy
251,514
+43,357
+21% +$1.83M 0.01% 1006
2015
Q2
$9.53M Buy
+208,157
New +$9.53M ﹤0.01% 1049